Search Results - "Vargo, Rita"

Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion by Fukamachi, Kiyotaka, McCarthy, Patrick M., Smedira, Nicholas G., Vargo, Rita L., Starling, Randall C., Young, James B.

“…Background. Implantable left ventricular assist device (LVAD) insertion complicated by early right ventricular (RV) failure has a poor prognosis and is…”
Get full text

One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology by McCarthy, Patrick M., Smedira, Nicholas O., Vargo, Rita L., Goormastic, Marlene, Hobbs, Robert E., Starling, Randall C., Young, James B.

“…Background: Implantable left ventricular assist devices are common as a bridge to transplantation but are just reaching their goal as an alternative to…”
Get full text

Early results with partial left ventriculectomy by McCarthy, Patrick M., Starling, Randall C., Wong, James, Scalia, Gregory M., Buda, Tiffany, Vargo, Rita L., Goormastic, Marlene, Thomas, James D., Smedira, Nicholas G., Young, James B.

“…Objective: We sought to determine the role of partial left ventriculectomy in patients with dilated cardiomyopathy. Methods: Since May 1996 we have performed…”
Get full text

Factors Influencing HLA Sensitization in Implantable LVAD Recipients by Massad, Malek G, Cook, Daniel J, Schmitt, Steven K, Smedira, Nicholas G, McCarthy, James F, Vargo, Rita L, McCarthy, Patrick M

“…Background. Patients bridged to transplantation (TX) with the implantable left ventricular assist device (LVAD) may be at increased risk for the development of…”
Get full text

Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure by James, K B, McCarthy, P M, Thomas, J D, Vargo, R, Hobbs, R E, Sapp, S, Bravo, E

“…The HeartMate left ventricular assist device has been successfully used as a bridge to cardiac transplantation. Because many patients exhibit marked clinical…”
Get full text

Implantable LVAD infections: Implications for permanent use of the device by McCarthy, Patrick M., Schmitt, Steven K., Vargo, Rita L., Gordon, Steven, Keys, Thomas F., Hobbs, Robert E.

“…Infection in implantable left ventricular assist device (LVAD) patients is common and has serious implications regarding permanent use of the LVAD…”
Get full text

Structural and left ventricular histologic changes after implantable LVAD insertion by McCarthy, Patrick M., Nakatani, Satoshi, Vargo, Rita, Kottke-Marchant, Kandice, Harasaki, Hiroaki, James, Karen B., Savage, Robert M., Thomas, James D.

“…Long-term support on the implantable left ventricular assist device (LVAD) produces structural changes in the recipient's heart. To assess the possibility of…”
Get full text

Prediction of right ventricular dysfunction after left ventricular assist device implantation by NAKATANI, S, THOMAS, J. D, SAVAGE, R. M, VARGO, R. L, SMEDIRA, N. G, MCCARTHY, P. M

“…Right ventricular dysfunction (RVD) significantly affects mortality and morbidity after left ventricular assist device (LVAD) implantation, and its occurrence…”
Get full text

Preperitoneal insertion of the HeartMate 1000 IP implantable left ventricular assist device by McCarthy, Patrick M., Wang, Nan, Vargo, Rita

“…During a 16-month period, 12 consecutive patients underwent insertion of a HeartMate 1000 IP left ventricular assist device in a preperitoneal pocket that…”
Get full text

Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome? by Massad, Malek G., McCarthy, Patrick M., Smedira, Nicholas G., Cook, Daniel J., Ratliff, Norman B., Goormastic, Marlene, Vargo, Rita L., Navia, Jose, Young, James B., Stewart, Robert W.

“…Objectives: We sought to determine whether cardiac transplant recipients who required a bridge to transplantation with an implantable left ventricular assist…”
Get full text

Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices by Oz, M C, Goldstein, D J, Pepino, P, Weinberg, A D, Thompson, S M, Catanese, K A, Vargo, R L, McCarthy, P M, Rose, E A, Levin, H R

“…Although use of long-term implantable left ventricular assist devices (LVAD) is becoming more popular, further reduction of the mortality rate accompanying…”
Get full text

A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin’s lymphoma weighing ≤70 kg by Kuruvilla, John, Tzeng, Cheng-Hwai, Cho, Seok-Goo, Kim, Seok Jin, Tang, Jih-Luh, Su, Yaming, Wu, Jingyang, Vargo, Rita, Cheverton, Peter

“…A randomized, multicenter, open-label study explored the effect of a fixed-dose (FD) of plerixafor versus the approved weight-based (WB) dose for the…”
Get full text

Permanent mechanical circulatory support with an implantable left ventricular assist device by McCarthy, Patrick M., Young, James B., Smedira, Nicholas G., Hobbs, Robert E., Vargo, Rita L., Starling, Randall C.

“…A 67-year-old man had end-stage ischemic cardiomyopathy. He had had two previous coronary bypass operations and a previous left ventricular aneurysmectomy. In…”
Get full text

Extended cardiac support with a portable left ventricular assist system in the home by Myers, T J, Catanese, K A, Vargo, R L, Dressler, D K

“…Since 1986, the HeartMate left ventricular assist system (LVAS) has been widely used as a bridge to transplantation. Recently, a multicenter study was…”
Get more information

Pulmonary hypertension is not a risk factor for RVAD use and death after left ventricular assist system support by Smedira, N G, Massad, M G, Navia, J, Vargo, R L, Patel, A N, Cook, D J, McCarthy, P M

“…Unlike transplantation candidates, patients with pulmonary hypertension (PHTN) and a high transpulmonary gradient do not appear to be at increased risk for…”
Get more information

Hemostatic profiles of HeartMate ventricular assist device recipients by Wang, I W, Kottke-Marchant, K, Vargo, R L, McCarthy, P M

“…Candidates for ventricular assist devices often have hepatic dysfunction and concomitant coagulation abnormalities. Factors II, V, VII, XI, plasminogen,…”
Get more information

Age related outcome after implantable left ventricular assist system support by Smedira, N G, Dasse, K A, Patel, A N, Vargo, R L, Massad, M G, McCarthy, P M

“…To examine the relationship between age and outcome after implantable left ventricular assist system support, the authors investigated the results of 223…”
Get more information

Assistência circulatória com aparelho Heart Mate® na Cleveland Clinic Foundation: experiência inicial e futuras aplicações by GAUZE, Theófilo, VARGO, Rita, HOOK, Robert, SAVAGE, Robert, McCARTHY, Patrick M

“…Objetivo: Estudar a experiência inicial em assistência circulatória ventricular esquerda com o aparelho pneumático implantável Heart Mate® 1000 IP, analisando…”
Get full text

Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report by Micallef, Ivana N., Stiff, Patrick J., Nademanee, Auayporn P., Maziarz, Richard T., Horwitz, Mitchell E., Stadtmauer, Edward A., Kaufman, Jonathan L., McCarty, John M., Vargo, Rita, Cheverton, Peter D., Struijs, Martin, Bolwell, Brian, DiPersio, John F.

“…•The addition of plerixafor to G-CSF did not affect clinical or long-term safety outcomes.•No differences were noted in 5-year OS/PFS for plerixafor-treated…”
Get full text

The role of the registered nurse-first assistant in the implantable left ventricular assist device program by Hlozek, C C, Zacharias, W M, Vargo, R L, Elias, B A, Yeager, M, McCarthy, P M

“…Successful support of patients using the implantable left ventricular assist device requires sustained and coordinated efforts by physicians and medical…”
Get more information